Tower Research Capital (TRC)’s Alvotech ALVO Stock Holding History
Bought
Maintained
Sold
Other funds holding ALVO
VCM
BCL
LC
VFT
Tower Research Capital (TRC)'s ALVO Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its Alvotech (ALVO) stake by 58% in Q1 2026, buying an estimated $8.54K and bringing the position to 5,288 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3546.
Tower Research Capital (TRC) first reported a position in ALVO in Q2 2022 and has held it in 8 quarters since. The position peaked at $80.5K in Q1 2025. 57 funds tracked by Wall St. Rank hold ALVO as of Q1 2026.
- Tower Research Capital (TRC) held 5,288 shares of Alvotech worth $18.1K as of Q1 2026.
- Tower Research Capital (TRC) bought 1,943 Alvotech shares in Q1 2026, an estimated $8.54K.
- Alvotech made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3546 holding.
- Tower Research Capital (TRC) first reported a position in Alvotech in Q2 2022 and has held it in 8 quarters since.
- Tower Research Capital (TRC)'s Alvotech position peaked at $80.5K in Q1 2025.
- 57 funds tracked by Wall St. Rank held Alvotech as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.